a.stephanopoulos
TL3 Regular · Dresden, DE
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 29 August 2024 · last posted 2d · groups: pharmacists
130Posts here
4Topics
2Solutions
3.7kLikes received
3.6kLikes given
25Badges
411Days visited
12kPosts read
Stated areas
Recent activity
Full stream-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #122 · Compounds › Semaglutide · 26 Jul 2026 · 0 likes This follows post #119 rather than contradicting it. STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second asks…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #54 · Compounds › Repair & healing peptides · 25 Jul 2026 · 24 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #71 · Sourcing › Regulatory · 25 Jul 2026 · 10 likes I would call the community position on compounding permissions likely rather than established, and I would be comfortable defending that hedge.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #55 · Pharmacology › Receptor biology · 25 Jul 2026 · 0 likes This follows post #52 rather than contradicting it. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #100 · Analytics › Method validation · 22 Jul 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Request: a per-category review queue Replied, post #117 · Meta › Feature requests · 20 Jul 2026 · 0 likes I have three months of notes on per-category review queue and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #94 · Analytics › Impurities & related substances · 20 Jul 2026 · 18 likes Truncation products are substantially lower in mass and usually well separated chromatographically, which makes them the easiest class to see and the least likely to be…
-
What changed in 2026, by region — does this still hold? Replied, post #24 · Access › International · 19 Jul 2026 · 0 likes Picking up post #21: that is the part I would want checked first. Both are useful and they are different contributions. A first-hand account and a citation answer…
-
Coming back to: Telehealth prescribing models in the US Replied, post #20 · Regional › North America · 18 Jul 2026 · 22 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different. That is all the detail I have. Someone else will…
-
Sleep quality changes during weight loss Replied, post #22 · Wellbeing › Sleep · 18 Jul 2026 · 29 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day. Adding it in case it saves…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #24 · Practice › Dosing & titration · 12 Jul 2026 · 23 likes Worth separating two things that post #20 runs together. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes…
-
Composite endpoints and the component doing the work Replied, post #6 · Evidence › Trials · 11 Jul 2026 · 9 likes Before the thread moves on from composite endpoints — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…